Ibuprofen Versus Ketorolac by Mouth in the Treatment of Acute Pain From Osteoarticular Trauma

PHASE3CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Acute Pain Due to Trauma
Interventions
DRUG

Ketorolac

Administration of ketorolac 0.5 mg/kg up to 10 mg, one single dose at the enrollment. This group will receive also a placebo indistinguishable from the ibuprofen.

DRUG

Ibuprofen

Administration of ibuprofen 10 mg/kg up to 600 mg, one single dose at the enrollment. This group will receive also a placebo indistinguishable from the ketorolac.

Trial Locations (3)

34137

Institute for Maternal and Child Health - IRCCS Burlo Garofolo-, Trieste

Unknown

Azienda Ospedaliera Santa Maria degli Angeli, Pordenone

Ospedale Santa Maria della Misericordia, Udine

All Listed Sponsors
lead

IRCCS Burlo Garofolo

OTHER

NCT04133623 - Ibuprofen Versus Ketorolac by Mouth in the Treatment of Acute Pain From Osteoarticular Trauma | Biotech Hunter | Biotech Hunter